company background image
500660 logo

GlaxoSmithKline Pharmaceuticals BSE:500660 Stock Report

Last Price

₹1.98k

Market Cap

₹337.3b

7D

-5.3%

1Y

-11.0%

Updated

30 Jan, 2025

Data

Company Financials +

GlaxoSmithKline Pharmaceuticals Limited

BSE:500660 Stock Report

Market Cap: ₹337.3b

500660 Stock Overview

Manufactures, distributes, and trades in pharmaceuticals in India and internationally. More details

500660 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Rewards

Earnings are forecast to grow 16.38% per year

Earnings have grown 20.1% per year over the past 5 years

Analysts in good agreement that stock price will rise by 47.1%

Risk Analysis

Dividend of 1.62% is not well covered by earnings


My Notes

Capture your thoughts, links and company narrative

GlaxoSmithKline Pharmaceuticals Limited Competitors

Laurus Labs

NSEI:LAURUSLABS

₹293.2b

Ajanta Pharma

NSEI:AJANTPHARM

₹334.3b

Ipca Laboratories

NSEI:IPCALAB

₹366.2b

Emcure Pharmaceuticals

NSEI:EMCURE

₹228.6b

Price History & Performance

Summary of share price highs, lows and changes for GlaxoSmithKline Pharmaceuticals
Historical stock prices
Current Share Price₹1,981.35
52 Week High₹3,087.95
52 Week Low₹1,825.05
Beta0.24
1 Month Change-12.02%
3 Month Change-27.42%
1 Year Change-11.02%
3 Year Change27.67%
5 Year Change47.53%
Change since IPO1,584.46%

Recent News & Updates

Recent updates

Shareholder Returns

500660IN PharmaceuticalsIN Market
7D-5.3%-3.4%-1.4%
1Y-11.0%18.6%5.8%

Return vs Industry: 500660 underperformed the Indian Pharmaceuticals industry which returned 18.6% over the past year.

Return vs Market: 500660 underperformed the Indian Market which returned 5.8% over the past year.

Price Volatility

Is 500660's price volatile compared to industry and market?
500660 volatility
500660 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 500660 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 500660's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19243,211Bhushan Akshikarindia-pharma.gsk.com

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines comprising NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease.

GlaxoSmithKline Pharmaceuticals Limited Fundamentals Summary

How do GlaxoSmithKline Pharmaceuticals's earnings and revenue compare to its market cap?
500660 fundamental statistics
Market cap₹337.26b
Earnings (TTM)₹6.75b
Revenue (TTM)₹35.60b

49.7x

P/E Ratio

9.4x

P/S Ratio

Is 500660 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500660 income statement (TTM)
Revenue₹35.60b
Cost of Revenue₹13.84b
Gross Profit₹21.76b
Other Expenses₹15.01b
Earnings₹6.75b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 10, 2025

Earnings per share (EPS)39.85
Gross Margin61.12%
Net Profit Margin18.96%
Debt/Equity Ratio0%

How did 500660 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

92%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 13:27
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

GlaxoSmithKline Pharmaceuticals Limited is covered by 25 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shirish PardeshiAnand Rathi Shares and Stock Brokers Limited
Sarabjit NangraAngel Broking Private Limited
Prakash AgarwalAxis Capital Limited